Study co-author Dr. Nicholas J. Petruzzi, MD, FSIR presented “One-Year Clinical and Lifetime Cost-Effectiveness Outcomes of Transcatheter Arterialization for No-Option CLTI in the U.S.” at the SIR 2025 Annual Meeting. The analysis relies on a Wing Tech-developed cost-effectiveness framework and was selected as one of the SIR ‘Abstracts of the Year’.
